Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Viracept-EMS case: impact and outlook.

Toxicology letters - 12 Nov 2009

Walker Vernon E, Casciano Daniel A, Tweats David J

Abstract excerpt

This perspective first considers the potential impact of the Viracept-EMS case in the framework of the current understanding of the low-dose effects of DNA-reactive chemicals and the approaches used to estimate health risks from genotoxins occurring as impurities in pharmaceutical products or as contaminants in the environment or workplace. It also presents an outlook on the nature of additional research building...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkylating Agents
Share to Drug Contamination
Share to Environmental Exposure

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ethyl Methanesulfonate

Share to HIV Protease Inhibitors

Share to Mutagenicity Tests

Share to Mutagens

Share to Nelfinavir

Source

Identifiers

PMID: 19866516
DOI: 10.1016/j.toxlet.2009.03.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Viracept-EMS case: impact and outlook.PMID 19866516Read ↗

Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.Semantic proximity Read ↗

The UKEMS collaborative genotoxicity trial organisation, selection criteria and preparation of the chemicals.Semantic proximity Read ↗

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT).Semantic proximity Read ↗

Comprehensive genotoxicity and carcinogenicity assessment of molnupiravirSemantic proximity Read ↗

A review of human carcinogens—Part A: pharmaceuticalsSemantic proximity Read ↗

Genotoxicity evaluation of gene therapies: highlights from IWGT 2022Semantic proximity Read ↗

Threshold and non-threshold chemical carcinogens: A survey of the present regulatory landscapeSemantic proximity Read ↗

IARC Monographs on the Evaluation of Carcinogenic Risks to HumansSemantic proximity Read ↗

IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs).Semantic proximity Read ↗

Genetic Toxicity Assessment: Employing the Best Science for Human Safety Evaluation Part IV:Recommendation of a Working Group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a Simple and Straightforward Approach to Genotoxicity TestingSemantic proximity Read ↗

The Industrial Genetic Toxicology Discussion Group Meeting on in vitro and in vivo micronucleus tests.Semantic proximity Read ↗

[Genotoxicity tests as a safety study required for the development of pharmaceuticals].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.